Gilles Crehange

Summary

Publications

  1. doi request reprint Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapy
    Gilles Crehange
    Department of Radiation Oncology, Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, USA Department of Radiation Oncology, Dijon University Hospital, France Electronic address
    Radiother Oncol 109:246-50. 2013
  2. pmc Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm
    Gilles Crehange
    Department of Radiation Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 1600 Divisadero Street, CA 94143, San Francisco, United States
    Cancer Treat Rev 38:956-67. 2012
  3. doi request reprint [Image-guided radiotherapy in prostate cancer: concepts and implications]
    G Crehange
    Departement de Radiotherapie, Centre Georges Francois Leclerc, Dijon, France
    Cancer Radiother 16:430-8. 2012
  4. doi request reprint Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer
    Gilles Crehange
    Department of Radiation Oncology, Centre Georges Francois Leclerc, Dijon, France
    Radiother Oncol 103:244-6. 2012
  5. doi request reprint Early choline levels from 3-tesla MR spectroscopy after exclusive radiation therapy in patients with clinically localized prostate cancer are predictive of plasmatic levels of PSA at 1 year
    Gilles Crehange
    Department of Radiation Oncology, Anticancer Centre Georges François Leclerc, Dijon, France
    Int J Radiat Oncol Biol Phys 81:e407-13. 2011
  6. doi request reprint Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology
    Gilles Crehange
    Department of Radiation Oncology, Centre Georges Francois Leclerc, Dijon, France
    Int J Radiat Oncol Biol Phys 80:1087-94. 2011
  7. doi request reprint [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies]
    G Crehange
    Departement de Radiotherapie, Centre Georges Francois Leclerc, 1, rue du Professeur Marion, 21000 Dijon, France
    Cancer Radiother 15:440-4. 2011
  8. pmc Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
    Claire Vautravers Dewas
    Department of Radiation Oncology, Anticancer center Georges François Leclerc, 1 rue du Professeur Marion, Dijon 21000, France
    Radiat Oncol 7:201. 2012
  9. pmc Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups
    Caroline Azelie
    Department of Radiation Oncology, Anticancer center Georges François, Leclerc, 1 rue du Professeur Marion, 21000, Dijon, France
    Radiat Oncol 7:158. 2012
  10. ncbi request reprint Tumor volume as outcome determinant in patients treated with chemoradiation for locally advanced esophageal cancer
    Gilles Crehange
    Department of Radiation Oncology, Besancon University Hospital, France
    Am J Clin Oncol 29:583-7. 2006

Collaborators

Detail Information

Publications20

  1. doi request reprint Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapy
    Gilles Crehange
    Department of Radiation Oncology, Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, USA Department of Radiation Oncology, Dijon University Hospital, France Electronic address
    Radiother Oncol 109:246-50. 2013
    ..1) To establish a method to evaluate dosimetry at the time of primary prostate permanent implant (pPPI) using MRI of the shrunken prostate at the time of failure (tf). (2) To compare cold spot mapping with sextant-biopsy mapping at tf...
  2. pmc Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm
    Gilles Crehange
    Department of Radiation Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 1600 Divisadero Street, CA 94143, San Francisco, United States
    Cancer Treat Rev 38:956-67. 2012
    ..This review highlights advances in imaging and reports how they may help to define a new paradigm to manage node-positive prostate cancer patients with a curative-intent...
  3. doi request reprint [Image-guided radiotherapy in prostate cancer: concepts and implications]
    G Crehange
    Departement de Radiotherapie, Centre Georges Francois Leclerc, Dijon, France
    Cancer Radiother 16:430-8. 2012
    ..Recommendations are made for the repositioning protocols according to the most widely used repositioning techniques: fiduciary markers or soft tissues, kV-CBCT or MV-CBCT, 3D ultrasonography...
  4. doi request reprint Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer
    Gilles Crehange
    Department of Radiation Oncology, Centre Georges Francois Leclerc, Dijon, France
    Radiother Oncol 103:244-6. 2012
    ..3 months [5.25-87.3], bPFS at 3 years was 92.5% [82.4%-96.9%] in group A and 94.3% [85.5%-97.8%] in group B (p=0.84). IG-IMRT yielded very low rates of late toxicity. Margin had impact neither on short-term bPFS nor late toxicity...
  5. doi request reprint Early choline levels from 3-tesla MR spectroscopy after exclusive radiation therapy in patients with clinically localized prostate cancer are predictive of plasmatic levels of PSA at 1 year
    Gilles Crehange
    Department of Radiation Oncology, Anticancer Centre Georges François Leclerc, Dijon, France
    Int J Radiat Oncol Biol Phys 81:e407-13. 2011
    ..To investigate the time course response of prostate metabolism to irradiation using magnetic resonance spectroscopy (MRS) at 3-month intervals and its impact on biochemical control...
  6. doi request reprint Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology
    Gilles Crehange
    Department of Radiation Oncology, Centre Georges Francois Leclerc, Dijon, France
    Int J Radiat Oncol Biol Phys 80:1087-94. 2011
    ....
  7. doi request reprint [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies]
    G Crehange
    Departement de Radiotherapie, Centre Georges Francois Leclerc, 1, rue du Professeur Marion, 21000 Dijon, France
    Cancer Radiother 15:440-4. 2011
    ....
  8. pmc Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
    Claire Vautravers Dewas
    Department of Radiation Oncology, Anticancer center Georges François Leclerc, 1 rue du Professeur Marion, Dijon 21000, France
    Radiat Oncol 7:201. 2012
    ..Intensity-modulated radiation therapy (IMRT) makes it possible to reduce treatment time by abandoning this gap. The purpose of this study was to compare outcomes and toxicities in patients treated with either IMRT or 3D-CRT...
  9. pmc Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups
    Caroline Azelie
    Department of Radiation Oncology, Anticancer center Georges François, Leclerc, 1 rue du Professeur Marion, 21000, Dijon, France
    Radiat Oncol 7:158. 2012
    ..To investigate whether patients treated for a localized prostate cancer (PCa) require a radical prostatectomy followed by postoperative radiotherapy or exclusive radiotherapy, in the modern era of image guided IMRT...
  10. ncbi request reprint Tumor volume as outcome determinant in patients treated with chemoradiation for locally advanced esophageal cancer
    Gilles Crehange
    Department of Radiation Oncology, Besancon University Hospital, France
    Am J Clin Oncol 29:583-7. 2006
    ..There is a need for both an efficient, easy-to-perform clinical classification and for identification of pretherapeutic prognostic factors that would be useful for oncologists, one of which is tumor volume...
  11. doi request reprint Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer
    Charles C Hsu
    Department of Radiation Oncology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California 94115, USA
    Int J Radiat Oncol Biol Phys 85:370-7. 2013
    ..To assess the feasibility of magnetic resonance imaging (MRI)-planned partial salvage permanent prostate implant (psPPI) among patients with biopsy-proven local recurrence after initial PPI without evidence of distant disease...
  12. ncbi request reprint Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102
    Gilles Crehange
    Department of Radiation Oncology, Centre Georges Francois Leclerc, Dijon, France
    J Clin Oncol 25:4895-901. 2007
    ..We investigated the heterogeneity of the treatment benefits across subgroups of patients, defined according to the radiation scheme...
  13. ncbi request reprint Intensity-modulated radiation therapy in head and neck cancer: prescribed dose, clinical challenges and results
    Etienne Martin
    Department of Radiation Oncology, Centre Georges Francois Leclerc, Dijon Cedex, France
    Radiother Oncol 85:392-8. 2007
    ..To analyse clinical and dosimetric characteristics with regard to clinical constraints in head and neck cancer patients treated with intensity-modulated radiotherapy (IMRT)...
  14. doi request reprint In-vivo metabolic characterization of healthy prostate and orthotopic prostate cancer in rats using proton magnetic resonance spectroscopy at 4.7 T
    Paul Walker
    LE2I, UMR 5158 CNRS, University of Burgundy, Dijon, France
    Acta Radiol 54:121-6. 2013
    ..In order to improve the predictivity of preclinical experiments, more realistic animal models are needed, for example, tumors xenografted directly on the prostate gland of rodents...
  15. doi request reprint Adjuvant treatments for gastric cancer: From practice guidelines to clinical practice
    Anne Marie Bouvier
    University Hospital Dijon Digestive Cancer Registry of Burgundy Inserm U866 University of Burgundy, Dijon, F 21079, France Electronic address
    Dig Liver Dis 46:72-5. 2014
    ..The aim of this study was to evaluate the diffusion of adjuvant treatments in a French population...
  16. ncbi request reprint Clinical assessment of the use of the Sonarray system for daily prostate localization
    Karine Peignaux
    Department of Radiation Oncology, Centre Georges Francois Leclerc, Dijon, France
    Radiother Oncol 81:176-8. 2006
    ..We reported both setup errors and organ motion detected by Sonarray system and the accuracy of this ultrasound imaging dedicated to radiotherapy...
  17. ncbi request reprint Combining cisplatin and mitomycin with radiotherapy in anal carcinoma
    Gilles Crehange
    Department of Radiation Oncology, Besancon University Hospital, Besancon, France
    Dis Colon Rectum 50:43-9. 2007
    ..We tested the feasibility of chemoradiation in anal carcinoma with mitomycin and cisplatin in a phase II study...
  18. doi request reprint Stereotactic Body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapy
    Elodie Nouhaud
    Department of Radiation Oncology and Surgical Oncology, Anticancer Centre Georges François Leclerc, 21079 Dijon Cedex, France
    BMC Res Notes 6:492. 2013
    ..To evaluate the feasibility and efficacy of Stereotactic body radiation therapy (SBRT) for primary liver lesions and liver metastases treated with linear accelerators with or without rotational Intensity Modulated RadioTherapy (IMRT)...
  19. doi request reprint Pathological response and survival after neoadjuvant therapy for breast cancer: a 30-year study
    Séverine Guiu
    Department of Medical Oncology, Georges Francois Leclerc Cancer Center, Dijon, France
    Breast 22:301-8. 2013
    ..The aim of this study was to reconsider these parameters on a large population after a long follow-up. 348 patients with unilateral breast cancer who received neoadjuvant treatment at our institution over 30 years were included...
  20. ncbi request reprint [Main indications of radiation oncology]
    Philippe Maingon
    Centre Georges Francois Leclerc, Departement de Radiotherapie, 21079 Dijon Cedex
    Rev Prat 61:79-80, 82-4. 2011
    ..The technological improvements are introducing stereotactic treatments, for lung carcinoma and liver tumors not amenable to curative approaches by surgery...